Abbie Stockard, a 22-year-old nursing student and cheerleader at Alabama’s Auburn University, beat 51 other contestants to be ...

RCT-2100 is under development for the treatment of cystic fibrosis (CF). The therapeutic candidate is an mRNA, encoding cystic fibrosis transmembrane conductance regulator (CFTR). It is administered ...

Galicaftor is under clinical development by Sionna Therapeutics and currently in Phase II for Cystic Fibrosis.

Vertex has won two cystic fibrosis approvals from the FDA, but the agency included high-level safety warnings.

As Vertex Pharmaceuticals reels from a painful trial readout for its pain candidate suzetrigine, the Boston biotech has ...

The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Cystic fibrosis is a genetic disorder that affects various organs, including the lungs and digestive system. Medications are important for managing symptoms, but there is currently no cure for the ...

Miss America pageant will take place in Orlando on January 5. This year's contestants include a national figure skater and a ...

A new charity football team in Peterborough has been set up to honour the memory of Jordan Smith and raise awareness of ...

Abbie Stockard won the competition Sunday night. Stockard was crowned Miss Alabama 2024 on June 29 at the Wright Center ...